• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 9-23 of 1,124 results

116 Order Denying Director Review of Institution Decision: Order Denying Director ...

Document IPR2023-00724, No. 116 Order Denying Director Review of Institution Decision - Order Denying Director Review of Institution Decision (P.T.A.B. Oct. 24, 2024)

cite Cite Document

19 Institution Decision Joined: Decision Granting Institution of Inter Partes Review ...

Document IPR2024-00009, No. 19 Institution Decision Joined - Decision Granting Institution of Inter Partes Review Granting Motion for Joinder (P.T.A.B. Apr. 25, 2024)

cite Cite Document

99 Order Other: Amended Order Setting Oral Argument 37 CFR 4270

Document IPR2023-00724, No. 99 Order Other - Amended Order Setting Oral Argument 37 CFR 4270 (P.T.A.B. Sep. 12, 2024)

cite Cite Document

88 Order Other: Order Conduct of the Proceeding 37 CFR sec 425

Document IPR2023-00724, No. 88 Order Other - Order Conduct of the Proceeding 37 CFR sec 425 (P.T.A.B. Aug. 26, 2024)

cite Cite Document

16 Order on Motion: ORDER Conduct of the Proceeding 37 CFR § 425

Document IPR2024-00009, No. 16 Order on Motion - ORDER Conduct of the Proceeding 37 CFR § 425 (P.T.A.B. Mar. 29, 2024)

cite Cite Document

78 Order Other: ORDER Setting Oral Argument

Document IPR2023-00724, No. 78 Order Other - ORDER Setting Oral Argument (P.T.A.B. Aug. 14, 2024)

cite Cite Document

No. 24

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 24 (N.D.W.Va. May. 9, 2022)

cite Cite Document

8 Notice Notice filing date accorded: Notice Notice filing date accorded

Document IPR2024-00631, No. 8 Notice Notice filing date accorded - Notice Notice filing date accorded (P.T.A.B. Mar. 12, 2024)

cite Cite Document

69 Order on Motion: ORDER Conduct of the Proceeding 37 CFR §§ 425

Document IPR2023-00724, No. 69 Order on Motion - ORDER Conduct of the Proceeding 37 CFR §§ 425 (P.T.A.B. Jul. 26, 2024)

cite Cite Document

No. 17

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 17 (N.D.W.Va. Mar. 29, 2022)

cite Cite Document

No. 16

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 16 (N.D.W.Va. Mar. 29, 2022)

cite Cite Document

No. 18

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 18 (N.D.W.Va. Mar. 29, 2022)

cite Cite Document

No. 15

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 15 (N.D.W.Va. Mar. 29, 2022)

cite Cite Document

No. 8

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 8 (N.D.W.Va. Mar. 28, 2022)

cite Cite Document

No. 7

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 7 (N.D.W.Va. Mar. 25, 2022)

cite Cite Document
<< 1 2 3 4 5 ... >>